美国食品和药物管理局 (FDA) 委员会召开会议,决定是否需要为秋冬更新COVID-19疫苗. FDA panel meets to decide if COVID-19 vaccines need updates for fall and winter.

FDA 正在召集专家讨论更新 COVID-19 疫苗，以便在秋季和冬季提供更好的保护，此前政策变化将加强针限制在老年人和高危人群。 The FDA is convening experts to discuss updating COVID-19 vaccines for better protection in the fall and winter, following a policy change limiting boosters to seniors and high-risk individuals. 小组将审查病毒是否已经变异到足以要求Pfizer、现代和Novavax疫苗进行菌株更新。 The panel will review if the virus has mutated enough to require strain updates for Pfizer, Moderna, and Novavax vaccines. 这次会议是在新的行政政策对疫苗资格的不确定性中召开的。 The meeting comes amid uncertainty over vaccine eligibility under new administration policies.